NV5 Share Price Performance
€0.038
-0.01 (-15.27%)
Price €0.038
Share Pricen/a
AcuCort (BST:NV5) Is In A Good Position To Deliver On Growth Plans
Dec 03
AcuCort AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
NV5 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
AcuCort AB (publ) Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -0.11
- -139.38%
- -312.21%
- 0%
About NV5
- Founded
- 2006
- Employees
- 4
- CEO
- WebsiteView website
AcuCort AB (publ) operates as a pharmaceutical company. It offers Zeqmelit, an oral film containing the glucocorticoid dexamethasone for the treatment of acute allergic reactions, croup in children, nausea and vomiting associated with chemotherapy, and for the treatment of patients with COVID-19 who experience respiratory difficulties and require oxygen therapy. The company was incorporated in 2006 and is based in Lund, Sweden.
